Altea Therapeutics Achieves Successful Transdermal Delivery of Therapeutic Carbohydrate Macromolecules; Signs Research Agreement with Major Pharmaceutical Company
ATLANTA, Ga.--(BUSINESS WIRE)--Altea Therapeutics has entered into a research agreement with an undisclosed major pharmaceutical company to examine the feasibility of developing a transdermal patch product that delivers certain macromolecular carbohydrates for the treatment of coagulation disorders.